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Summary
Background Cyst infection remains a challenging issue in patients with autosomal dominant polycystic kid-
ney disease (ADPKD). In most patients, conventional imaging techniques are inconclusive. Isolated observa-
tions suggest that 18fluorodeoxyglucose (18FDG) positron-emission computed tomography (PET/CT) might
help detect cyst infection in ADPKD patients.
Design, setting, participants, & measurements Comparative assessment of administrative databases from Jan-
uary 2005 to December 2009 identified 27 PET/CT scans performed in 24 ADPKD patients for suspicion of
abdominal infection. Cyst infection was definite if confirmed by cyst fluid analysis. Cyst infection was
probable if all four of the following criteria were met: temperature of 38°C for 3 days, loin or liver ten-
derness, C-reactive protein plasma level of 5 mg/dl, and no CT evidence for intracystic bleeding. Epi-
sodes with only two or three criteria were grouped as “fever of unknown origin”.
Results Thirteen infectious events in 11 patients met all criteria for kidney (n  3) or liver (n  10) cyst in-
fection. CT was contributive in only one patient, whereas PET/CT proved cyst infection in 11 patients
(84.6%). In addition, 14 episodes of “fever of unknown origin” in 13 patients were recorded. PET/CT iden-
tified the source of infection in nine patients (64.3%), including 2 renal cyst infections. Conversely, PET/CT
showed no abnormal 18FDG uptake in 5 patients, including 2 intracystic bleeding. The median delay be-
tween the onset of symptoms and PET/CT procedure was 9 days.
Conclusions This retrospective series underscores the usefulness of PET/CT to confirm and locate cyst in-
fection and identify alternative sources of abdominal infection in ADPKD patients.
Clin J Am Soc Nephrol 6: 1644–1650, 2011. doi: 10.2215/CJN.06900810
Introduction
Autosomal dominant polycystic kidney disease
(ADPKD, Mendelian Inheritance in Man #173900)
represents the most common inherited kidney disease
and is characterized by the development of numerous
renal and hepatic cysts from various renal tubular
segments and biliary ducts, respectively (1,2). Cyst
growth causes organ enlargement leading to abdom-
inal and/or loin discomfort. Cysts are also associated
with acute complications, such as bleeding and infec-
tion. Cyst infection (CI) represents the most challeng-
ing diagnostic issue in patients with ADPKD, with a
substantial risk for abscess formation and life-
threatening sepsis (3). The diagnosis of CI remains
uneasy because of the lack of specific symptoms and
signs and the limitations of conventional imaging
procedures (4,5). The elevation of serum carbohydrate
antigen 19.9 (CA19.9) has been recently proposed as a
diagnostic marker for hepatic CI (6). In addition, iso-
lated reports have suggested that positron-emission
tomography (PET) after intravenous injection of
18fluorodeoxyglucose (18FDG) might help identify tis-
sue infection in ADPKD patients (7–11). Inflamma-
tory cells are indeed characterized by a high meta-
bolic activity and increased uptake of glucose analog,
18FDG (9). Moreover, the modern combination of PET
with computed tomography (CT) may improve the
localization of pyocysts by integrating metabolic and
anatomical data (12). This study retrospectively inves-
tigates the accuracy of PET/CT imaging in diagnos-
ing CI in ADPKD patients.
Study Population and Methods
The assessment of the computerized billing data-
base of the Universite´ catholique de Louvain Aca-
demic Saint-Luc Hospital (Brussels, Belgium) listed
all ADPKD patients admitted for suspicion of abdom-
inal infection from January 2005 to December 2009.
Among these patients, those who underwent a
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tive records of the Division of Nuclear Medicine. All of the
medical files were reviewed.
Diagnostic criteria for ADPKD were the presence of
polycystic kidneys in at-risk patients or, in the absence of
family history, the presence of more than three renal cysts
for individuals aged between 15 and 39 years, more than
two cysts in each kidney for individuals aged 40 to 59
years, and more than four cysts in each kidney for indi-
viduals aged 60 years (13). The diagnosis of renal and
liver CI was on the basis of the following criteria recently
proposed by Salle´e et al. (4): (1) CI was definite when
confirmed by cyst aspiration showing neutrophils and bac-
teria; (2) CI was probable in the concurrent manifestation
of four conditions—fever (temperature of 38°C for 3
days), abdominal tenderness in kidney or liver area, in-
creased C-reactive protein (CRP, 5 mg/dl), and the ab-
sence of CT arguments for recent intracystic bleeding, i.e.
spontaneous intracystic content above 50 Hounsfield units
in the original reads. Infectious episodes which met 2 or 3
of these criteria were categorized as “fever of unknown
origin” (FUO).
The PET/CT procedure was performed using the
PET/CT Philips GEMINI TF (Philips Medical Systems,
Brussels, Belgium) after intravenous injection of a mean
dose of 300  40.7 MBq (8.1  1.1 mCi) of 18FDG. PET
imaging was acquired in list mode and rebuilt in 4-mm
transaxial slices with isometric voxels using time-of-flight
reconstruction. Two transverse series of 2- and 5-mm slices
were concurrently generated from low dose helical CT. No
intravenous or oral radiologic contrast agent was admin-
istered at the time of PET/CT imaging. All of the PET/CT
were initially performed for suspicion of abdominal infec-
tion at the physicians’ discretion and read by 2 nuclear
medicine physicians with at least 10 years of PET experi-
ence. PET findings were further confronted to CT results
and discussed with 2 radiologists with at least 15 years of
experience. For the purposes of this study, all 27 of the
PET/CT images were methodically reviewed by one nu-
clear medicine physician with 10 years of experience un-
aware of any clinical, biologic, and radiologic data.
PET/CT was considered as positive for CI when 18FDG
uptake was focally increased lining at least one cyst, in
strong contrast with the physiologic accumulation in pa-
renchyma and distant from the pelvicalyceal physiologic
excretion (14). The maximal standardized uptake value
(SUVmax) was calculated for each patient using the fol-
lowing formula: [Pixel value (Bq/ml)  patient weight
(Kg)]/[injected dose (Bq)  1000 (g/kg)].
In addition, radiologic investigations performed inde-
pendently from PET/CT imaging, i.e. CT and magnetic
resonance (MR), were reviewed. The slice thickness of
CT images was 3 mm. Intravenous contrast agents were
systematically administered, except in patients with el-
evated serum creatinine level and/or declared allergy to
iodide. CT and MR imaging (MRI) were considered as
positive when enhanced wall thickening and focal in-
flammatory infiltrate were detected in at least one cyst.
This study was approved by the Commission of Biomed-
ical Ethics of the Universite´ catholique de Louvain
(Brussels, Belgium).
Results
From January 2005 to December 2009, 268 ADPKD pa-
tients were admitted to the Universite´ catholique de Lou-
vain Academic Saint-Luc Hospital (Brussels, Belgium). Ab-
dominal infection was suspected in 46 patients. Among
these, 27 PET/CT were performed in 24 patients. Thirteen
infectious events in 11 patients met all of the criteria for
kidney (n  3) or liver (n  10) CI, whereas 14 episodes in
13 patients only encountered 2 or 3 of them. The cohort
included 2 patients under chronic hemodialysis and 14
renal transplant recipients (RTR).
Liver Cyst Infections
Three liver CI in 3 patients were definite, as confirmed
by cyst fluid analysis. Clinical and biologic data are sum-
marized in Table 1. Blood cultures grew Gram-negative
bacteria in all cases (Table 2). CT imaging without contrast
agent was performed in all cases but was contributive in
only one. Conversely, PET/CT demonstrated a pathologic
increase of 18FDG uptake lining liver pyocyst (Figure 1) in
all cases, which guided cyst drainage.
In addition, seven liver CI were probable in five patients
(Table 1). Blood cultures grew Escherichia coli in two pa-
tients (Table 2). CT imaging with (n  2) or without (n 
3) contrast agent was performed in four patients but did
not meet diagnostic criteria for CI in any of them. One
patient had two separate CT studies. PET/CT demon-
strated CI in six patients (85.7%) (Table 3). PET/CT was
negative in a 74-year-old woman admitted for fever, chills,
nausea, and pain in the right upper abdominal quadrant,
in whom kidney transplantation from a deceased donor
had been performed 19 days earlier. Clinical examination
confirmed liver tenderness. Plasma CRP level was 23.9
mg/dl (normal value [NV], 1 mg/dl); neutrophil white
blood cells (nWBC) count was 16.4  103/mm3 (NV, 7 
103/mm3); serum CA19.9 level was 80.1 units/ml (NV,
35 units/ml). Blood culture grew E. coli. CT with contrast
medium identified no infectious site and ruled out intra-
cystic bleeding. PET/CT performed 3 days after admission
revealed abnormal 18FDG uptake only in a thyroid nodule.
Empirical antibiotherapy was initiated with ceftazidim for
suspicion of liver CI and continued orally for 3 weeks with
amoxycillin/clavulanic acid. Symptoms and signs rapidly
resolved. The patient was discharged on day 10. Twelve
days after discharge, the patient presented with similar
symptoms. Antibiotics had been stopped 2 days earlier.
Blood analyses showed: CRP, 16.4 mg/dl; nWBC, 13.5 
103/mm3; CA19.9, 89.0 units/ml. Urine and blood cul-
tures remained germ-free. CT with contrast medium
showed no evidence of cyst infection or bleeding. Con-
versely, PET/CT performed on day 8 after admission iden-
tified a pathologic 18FDG accumulation lining cystic struc-
tures in the left part of the liver, in association with
segmental 18FDG uptake in the right colon. Ciprofloxacine
and metronidazole were started and planned for 6 weeks.
The patient was discharged on day 13. One week later, she
complained of two-sided calcaneal tendinitis. Ciprofloxa-
cine and metronidazole were interrupted, and amoxycil-
lin/clavulanic acid was resumed for 3 weeks. Ten days
later, she complained of epigastric pain. Blood analyses
showed increased CRP (15.7 mg/dl) and CA 19.9 (100.7
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units/ml) levels. Blood and urine cultures were sterile.
PET/CT imaging evidenced an increased 18FDG uptake in
distinct small cysts located in the right part of liver paren-
chyma. Because of the number, size, and location of in-
fected cysts, aspiration was not feasible. Intravenous met-
ronidazole and ceftriaxone were administered for 3 weeks,
with clinical and biologic improvement. Eighteen months
later, the patient remained free of liver CI, with baseline
CA19.9 at 47.6 units/ml.
Kidney Cyst Infections
Three kidney CIs were probable in 3 ADPKD patients
(Table 1). Urine cultures disclosed E. coli infection in two
patients, with one case of bacteriemia (Table 2). CT was
performed for all patients, with injection of contrast agent
in only one. No cyst infection or bleeding was found in any
case. MRI was performed in one of these patients and
identified a thick-walled, heterogeneous cyst spontane-
ously contrasting on T1-weighted images with parietal
enhancement after gadolinium injection (8). PET/CT con-
firmed CI in two patients by demonstrating a focal increase
of 18FDG uptake lining pyocysts (Figure 2) but failed to
evidence CI in a 62-year-old woman with stage IV chronic
kidney disease (CKD). She was admitted for fever, chills,
nausea, and right loin pain of 12 days of duration. Clinical
examination revealed a positive right lumbar percussion.
CRP was 10.0 mg/dl, and nWBC count was 6.5  103/
mm3. Urinalyses disclosed leucocyturia, but urine and
blood cultures remained negative. CT without contrast
agent did not evidence cyst infection or bleeding, and
PET/CT performed 8 days after admission showed a
pathologic 18FDG accumulation in the gastric wall second-
ary to active and diffuse Helicobacter pylori infection. Clas-
sical H. pylori treatment was administered for 7 days, and
antibiotherapy was continued for 21 days using ciprofloxa-
cine for suspicion of CI. The symptoms and signs progres-
sively regressed. The 1-year follow-up showed no recur-
rence of CI.
Fever of Unknown Origin in Patients with ADPKD
Fourteen PET/CT were performed in 13 ADPKD pa-
tients with suspicion of abdominal infection, which met
only 2 or 3 of the above-mentioned criteria for CI. Mean
nWBC count and CRP level were 8.2 3.2 103/mm3 and
16  10 mg/dl, respectively (Table 1). Twelve CT scans
were performed in 11 patients, with no contrast agent
injection in eight patients because of CKD. CT identified
renal intracystic bleeding in two patients, renal CI in one,
and diverticulitis of the small intestine in one, whereas no
infectious site could be identified in the remaining eight
episodes (66.7%). PET/CT showed no pathologic 18FDG
uptake in 5 patients (35.7%) including both cases of intra-
cystic bleeding, but identified distinct infectious diseases,
such as gastritis (n  1), angiocholitis (n  1), small intes-
tine diverticulitis associated with psoas abscess (n  1),
right colon diverticulitis (n  1), prostatitis (n  1), kidney
graft pyelonephritis (n  1), and infection of abdominal
aorta aneurysm (n  1). Typical 18FDG uptake lining renal
cysts was found in 2 patients (14.3%). The first patient was
an 81-year-old woman under hemodialysis for 6 years,
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plained of abnormal fatigue and macroscopic hematuria in
the absence of fever or pain. CRP was 24.2 mg/dl, and
nWBC count was 7.5  103/mm3. Urine sediment showed
both red and white blood cells, but the cultures remained
sterile. Blood cultures grew Klebsiella oxytoca. CT without
contrast agent because of iodide allergy showed no evi-
dence of cyst infection or bleeding. Conversely, PET/CT
identified a significant accumulation of 18FDG lining cystic
structures in the lower part of the left kidney. She was
treated with ciprofloxacine for 4 weeks with rapid im-
provement. The 2-year follow-up showed no recurrence of
CI.
The second patient was a 58-year-old RTR, with a past
history of 3 CI and right nephrectomy. At the outpatient
Table 2. Bacterial strains retrieved in 27 infectious episodes in 24 autosomal dominant polycystic kidney disease (ADPKD) patients
Urine Blood Cyst Fluid
Renal cyst infections (n) E. coli (2) E. coli (1)
Liver cyst infections (n) E. coli (4) E. coli (2)
K. pneumoniae (1) K. pneumoniae (1)
Fever of unknown origin (n) E. coli (3) E. coli (2)
K. pneumoniae (1) K. oxytoca (2)
E. cloacae (1)
One patient may present with positive cultures of urine and/or blood and/or cyst fluid samples. No causative bacterium was
found in 1 renal cyst infection (33%), 5 liver cyst infections (50%), and 6 episodes of fever of unknown origin (42.8%).
E. cloacae, Enterobacter cloacae; K. pneumoniae, Klebsiella pneumoniae; E. coli, Escherichia coli; K. oxytoca, Klebsiella oxytoca.
Figure 1. | Representative imaging of liver cyst infection diagnosis (arrow) using positron emission tomography (PET) after 18fluorodeoxy-
glucose injection, coupled with conventional computed tomography (CT). The merge between CT (A) and PET (C) imaging corresponds to
the central pictures (B). Coronal and transverse planes are shown in the upper and lower panels, respectively.
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transplant clinic, she reported a 6-day fluctuating lower
abdominal pain and chills, without urinary or digestive
symptoms. Clinical examination confirmed hypogastrium
tenderness. Urine culture was contaminated by Gram-neg-
ative bacteria. CRP was 8.1 mg/dl, and nWBC count was
8.9  103/mm3. CT without contrast medium showed one
large pyocyst in the left kidney with thickened wall and
distended renal fascia. PET/CT on day 9 after the onset of
Table 3. Positron-emission computed tomography (PET/CT) imaging results (n  27) in 24 autosomal dominant polycystic kidney
disease (ADPKD) patients
Cyst Infection
Fever of Unknown Origin
Liver Kidney
Definite Probable Probable CystInfection
No Cyst
Infection
PET/CT () 3 6 2 2 0
PET/CT (	) 0 1 1 0 12
n 3 7 3 2 12
Cyst infection is considered as definite when cyst aspiration shows neutrophil debris and bacteria. Cyst infection is probable in
the presence of all of the following symptoms and signs: fever (temperature above 38°C for more than 3 days), abdominal
tenderness located in the renal or liver area, increased C-reactive protein (5 mg/dl), and the absence of CT arguments for recent
intracystic bleeding. Infectious episodes that do not meet all of these criteria are referred to as “fever of unknown origin.”
Figure 2. | Representative imaging of kidney cyst infection diagnosis (arrow) using position emission tomography (PET) after 18fluorode-
oxyglucose injection, coupled with conventional computed tomography (CT). The merge between CT (A) and PET (C) imaging corresponds
to the central pictures (B). Coronal and transverse planes are shown in the upper and lower panels, respectively.
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abdominal symptoms confirmed the hypermetabolic status
of the infected cyst. Ciprofloxacine was administered for 4
weeks, with favorable evolution.
Features of PET/CT Imaging in Patients with ADPKD
The median delay between the onset of symptoms and
PET/CT imaging was 9 days. Seven patients (29.2%) were
diabetic, with a need for insulin in 3 of them. The mean
glycaemia at the time of 18FDG injection was 117.9  38.3
mg/dl. PET/CT imaging was usually acquired 95.3  31.1
minutes after 18FDG injection and yielded positive results
in 86.7% of CI cases (Table 3). Mean SUVmax measured in
the most metabolic pyocyst reached 5.1  1.7 g/ml.
PET/CT results significantly changed the management of 7
ADPKD patients presenting with suspicion of abdominal
infection (25.9%). By contrast, conventional CT failed to
detect the infected cyst in 84.6% of patients and yielded
negative results in 2 patients with definite liver CI (66.7%).
Discussion
The main diagnostic objectives in ADPKD patients pre-
senting with a suspicion of CI are (1) the exclusion of
noncystic infections; (2) the location and extension of in-
fected cysts; and (3) the identification of concomitant con-
ditions, like urinary tract obstruction (3). The lack of spe-
cific signs frequently retards the diagnosis and subsequent
treatment. The definite diagnosis of CI requires cyst fluid
analysis showing causative bacteria and neutrophils. How-
ever, this is not always possible or indicated, so that com-
mon criteria for CI rely on a constellation of clinical and
biologic parameters (4).
Conventional imaging procedures, like ultrasound, CT,
and MRI, frequently fail to confidently identify CI (3,4).
Radiologic features of pyocysts are unspecific and may be
secondary to previous infections and hemorrhages, as well
as chronic parenchyma injury. Cyst content of pus or blood
may be indistinguishable (3), and contrast enhancement
lining cyst walls can be caused by residual functional
parenchyma (15,16). Furthermore, CT is most frequently
performed in ADPKD patients without intravenous con-
trast medium because of CKD. Here, injection of contrast
medium was performed in 30.4% of patients, and CT im-
aging yielded contributive results in only five patients
(21.7%), including one with liver CI, one kidney with CI,
one with diverticulitis, and two with intracystic bleeding.
The accuracy of MRI in CI diagnosis, with and without
gadolinium injection, remains unknown.
To complement conventional radiologic procedures and
improve the accuracy of CI diagnosis, techniques using
radiolabeled tracers, like 111indium-labeled leukocytes and
18FDG, have been developed. The 111In-leukocyte scanning
allowed the identification of renal CI in a few ADPKD
patients in whom other noninvasive imaging procedures
had failed to locate the infection (17,18). However, this
technique requires the handling of blood derivatives and
the ex temporane in vitro labeling process, as well a 48-hour
delay before imaging. 111In-leukocyte scintigraphy is char-
acterized by low image resolution, uneasy coregistration,
and high interobserver variability (19). Moreover, the use
of 111In-leukocyte scanning in febrile RTR is inadequate
because of unspecific accumulation of leukocytes in renal
and pulmonary parenchymae (20). Recently, PET/CT us-
ing the glucose analog, 18FDG, has been proposed in the
detection and localization of tissue infection. Inflammatory
cells are indeed characterized by a high metabolic status
and increased uptake of 18FDG (9). PET/CT helped diag-
nose renal and hepatic CI in ADPKD patients with renal
function ranging frommildly reduced GFR to ESRD (7–11).
The advantages of 18FDG PET/CT are rapid imaging, high
target-to-background ratio, and a direct coregistration with
low-dose CT without radiologic contrast medium admin-
istration (21). Limitations include its relatively high cost
and restricted availability. In addition, 18FDG uptake is not
specific for infection and may be increased in other condi-
tions, like tumors. The actual risk of malignancy in AD-
PKD patients does not seem to be increased (22). Liver
cystadenocarcinomas are uncommon, and most kidney tu-
mors show low-grade malignancy leading to low 18FDG
uptake (14). The role of alternative tracers, like 18F-FLT, is
currently being addressed (23). Similarly, the differentia-
tion of 18FDG accumulation in residual parenchyma versus
that in inflammatory cells lining pyocysts remains debated
(24,25). Here, SUVmax measured in renal and hepatic pyo-
cysts significantly differed from baseline 18FDG uptake
(24). Moreover, 18FDG uptake in pyocyst wall was clearly
distinguishable using CT data coregistration (Figures 1 and 2).
The retrospective design of this monocentric study
based on administrative databases represents the main
limitation. This trial includes a small number of patients,
with only five renal CI, and relies upon past clinical re-
ports. All of the PET/CT images were blindly reviewed,
but the lack of accurate medical literature about PET/CT in
CI hampered the use of objective criteria, like SUVmax.
PET/CT imaging was considered as positive for CI when
18FDG uptake was focally increased lining at least one cyst
in strong contrast with the surrounding tissue. The mean
SUVmax reached 5.1  1.7 g/ml. This value needs to be
further assessed in prospective trials. PET/CT imaging
was contributive in 13 of 15 renal or hepatic CI, whereas
conventional CT identified only 2 CI. Moreover, PET/CT
evidenced 2 kidney CI, although both patients did not
meet all of the conventional criteria, and identified alter-
native sources of abdominal infection in 7 patients.
PET/CT yielded 2 false-negative results in one diabetic
RTR during the immediate post-transplantation period
and in a 62-year-old nondiabetic woman with stage IV
CKD. Technical conditions might partly explain these
false-negative results. In the first patient, the delay be-
tween the onset of symptoms and PET/CT was short (5
days), and the patient’s glycaemia at the time of 18FDG
injection (155 mg/dl) was significantly higher than the
mean of all procedures. In the other patient, PET/CT was
performed 20 days after the onset of fever, with an ex-
tended imaging delay (191 minutes). Current European
guidelines for PET/CT recommend (1) the intravenous
injection of 2.5 MBq/kg of body weight 18FDG activity
(10%), and (2) an interval between 18FDG administration
and the acquisition of 60 minutes (26). The efficiency of
PET/CT in immunocompromised patients remains poorly
established. PET/CT has been shown to distinguish AIDS-
related opportunistic infections from malignancies (27). In
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RTR and CKD patients, prospective trials investigating
PET/CT efficiency in identifying infectious sites are lacking.
The main differential diagnosis of CI in ADPKD patients
is intracystic bleeding. Significant cyst hemorrhage is usu-
ally detected by conventional CT, and the ability of
PET/CT to distinguish cyst infection versus bleeding re-
mains unknown. Increased 18FDG accumulation has been
reported in both acute and resolving hematoma in extrare-
nal sites (28,29). Here, 2 kidney cyst hemorrhages were
identified by CT, with no pathologic 18FDG accumulation.
Further prospective evaluations are required to establish
PET/CT accuracy in excluding intracystic bleeding and to
define the optimal delay between the onset of symptoms
and PET/CT imaging.
In conclusion, this retrospective series underscores the
usefulness of PET/CT to confirm and locate CI, as well as
to identify alternative sources of abdominal infection, in
ADPKD patients.
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